TLR4 and metabolic dysfunction-associated steatotic liver disease: Another research team has demonstrated TMBIM1 exerted anti-inflammatory protective role for chronic liver diseases including non-alcoholic fatty liver disease (NAFLD) via degradation of the TLR4 (Toll-like receptor 4) [23].